JANE PH D HSIAO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JANE PH D HSIAO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JANE PH D HSIAO. JANE PH D HSIAO is a Interim CEO in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and a Director in TRANSENTERIX INC. ($TRXC) and a Vice Chairman & CTO in Opko Health, Inc. ($EXEG) and a in Cocrystal Pharma, Inc. ($BZNE) and a Director in Cocrystal Pharma, Inc. ($COCP).

Over the past year JANE PH D HSIAO has been an insider in 4 companies. The total value of shares held by JANE PH D HSIAO in these companies amounts to $7,299,315.

JANE PH D HSIAO Director
Cocrystal Pharma, Inc.
Interim CEO
NON INVASIVE MONITORING SYSTEMS INC /FL/
Vice Chairman & CTO
Opko Health, Inc.
Director
TRANSENTERIX INC.
$ 7299315 The total value of shares held by JANE PH D HSIAO
Insider Rank

JANE PH D HSIAO ranks 4,257 out of 350,000 insiders. Go to Insider Ranking to see more.

Companies in which JANE PH D HSIAO is an Insider

Cocrystal Pharma, Inc.

Trading Symbol: COCP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JANE PH D HSIAO: Director
Holdings: 3,435,294 shares
Latest Transaction: Sep 24 2018

Last 4 weeks trend: HOLD
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 1,235,294
Shares Sold: 0
Share Difference: +1,235,294
Value Difference: -$630,000

NON INVASIVE MONITORING SYSTEMS INC /FL/

Trading Symbol: NIMU
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of JANE PH D HSIAO: Interim CEO
Holdings: 11,828,571 shares
Current Value: $2,247,428
Latest Transaction: Dec 27 2018
$NIMU Market Capitalization: $15.01M
$NIMU Previous Close: $0.19

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 54,471,468
Shares Sold: 0
Share Difference: +54,471,468
Value Difference: -$3,813,003

Opko Health, Inc.

Trading Symbol: EXEG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JANE PH D HSIAO: Vice Chairman & CTO
Holdings: 25,346,199 shares
Latest Transaction: Nov 13 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 21x
Sell: 0x
Shares Bought: 755,166
Shares Sold: 0
Share Difference: +755,166
Value Difference: -$3,370,285

TRANSENTERIX INC.

Trading Symbol: TRXC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JANE PH D HSIAO: Director
Holdings: 3,582,898 shares
Current Value: $5,051,886
Latest Transaction: May 29 2018
$TRXC Market Capitalization: $159.93M
$TRXC Previous Close: $1.41

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 420,362
Shares Sold: 0
Share Difference: +420,362
Value Difference: -$660,000

Latest Insider Trading Transactions of JANE PH D HSIAO

Sentiment: All, COCP, NIMU, EXEG, TRXC

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.0720,883,6601,461,85620,883,6600 to 20.9 M
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.074,923,503344,64516,752,07411.8 M to 16.8 M (+41.62 %)
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.071,428,571100,00011,828,57110.4 M to 11.8 M (+13.74 %)
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.0720,883,6601,461,85620,883,6600 to 20.9 M
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.074,923,503344,64516,752,07411.8 M to 16.8 M (+41.62 %)
Dec 27 2018NIMUNON INVASIVE MONIT ...HSIAO JANE PH DInterim CEOBuyP0.071,428,571100,00011,828,57110.4 M to 11.8 M (+13.74 %)
Nov 13 2018EXEGOpko Health, Inc.HSIAO JANE PH DVice Chairman & CTOGrantA3.49573,0662,000,00025,346,19924.8 M to 25.3 M (+2.31 %)

View all JANE PH D HSIAO insider transactions.